Medical Injection Molding Guide (Traceability, Biocompatible)

Medical parts demand documented process

A medical component is only as good as its traceability. The part, the resin lot and the process record must line up for audit — a device that cannot be traced back to its material and machine cannot be released, no matter how clean it looks on the bench. Specifying a medical molded part means matching biocompatible resin, sterilization resistance and a documented process to the risk class it lives in.

This guide is written from the buyer’s side: which resins clear biocompatibility and sterilization, what the clean-production and traceability requirements actually demand, and where the cost and validation really sit for a medical molding program.

The Snapshot

Biocompatibility is governed by ISO 10993 (and US USP Class VI for plastics contacting the body) — the resin must ship with a cert, not a promise.
LSR (liquid silicone rubber) resists gamma, EtO and autoclave sterilization and ran our ECG button program at 300K units/year, ±0.03 mm, 7 weeks rapid tooling.
PEI (Ultem) passed a Tier-1 medical-imaging balun at 15,000+ units/year with 8 weeks DFM-to-PPAP and full lot certs — continuous ~170 °C for repeated heat cycles.
Clean production typically means ISO Class 7 (Class 10,000) or tighter for device-critical parts; particulate and extractables are controlled per program.
Medical molding tolerance is ±0.05 mm on critical features (mold steel ±0.02 mm); general features sit in ±0.1–0.2 mm.
Lead time from DFM to validated production runs 8–12 weeks; rapid tooling for clinical builds pulls first parts to 3–5 weeks.

Material selection by device class

Medical plastics are not one category. The biggest spec error is selecting a consumer-grade resin for a device that sees body contact or repeated sterilization, because the quote was lower.

Biocompatible thermoplastics

For housings, enclosures and structural components:

Material	Service temp	Why use it	Watch-outs
PEI (Ultem)	170 °C	Autoclave-capable, stable dielectric, inherent UL94 V-0	Moisture-sensitive pre-dry; amorphous shrink 0.5–0.7%
PC / PC-ABS	100–125 °C	Transparent options, impact, gamma-stable	Stress-crack risk with some disinfectants
PEEK	250 °C	Implant-adjacent, chemical resistance, low outgassing	High resin cost; high melt needs hardened steel
PP	100–120 °C	Low cost, chemical resistant, disposable devices	Lower temp ceiling; HDT ~60 °C

Rule of thumb: if the part is sterilized by autoclave (>120 °C steam), choose PEI/PEEK over PC/ABS. If it is gamma or EtO only, PC/ABS and PP qualify at lower cost.

Liquid silicone rubber (LSR)

LSR is the standard for seals, gaskets and soft-touch medical parts because it survives repeated sterilization and remains flexible from −40 °C to 200 °C.

Medical-grade LSR is platinum-cured, low extractables, and bonds well to thermoplastics in two-shot or overmolding.
Our ECG button ran LSR (medical grade) at ±0.03 mm, 300K units/year, 7 weeks — a clean illustration of low-volume medical validation.
Shrinkage is high (2–3%) and anisotropic; tooling must be cut to the shrink, not the nominal.

Sterilization resistance

The sterilization cycle, not the operating condition, often decides the resin.

Gamma irradiation (typically 25–50 kGy) embrittles some resins (PP, some ABS) — PC and PEI hold better.
EtO (ethylene oxide) suits heat-sensitive parts but requires aeration to clear residuals.
Autoclave (steam, 121–134 °C) demands high-heat resins — PEI and PEEK survive repeated cycles; commodity ABS (max ~80–100 °C) cannot.
Chemical disinfectants (alcohol, quaternary ammonium) can stress-crack PC — verify compatibility per program.

A part validated for gamma that later ships to an autoclave line will fail in the field. The sterilization method is a print-level decision, not a post-launch change.

Clean production and contamination control

Device-critical parts require controlled environment and handling.

ISO Class 7 (Class 10,000) cleanroom molding is common for device-contact and implant-adjacent parts; tighter Class 6/5 for the most critical.
Extractables & leachables (E&L) testing per ISO 10993-18 documents what the resin can release into the body or drug — the material dossier must cover this.
Particulate control, dedicated tooling and controlled packaging prevent foreign-material contamination between molding and sterilization.

Tolerances and validation

A print that calls ±0.05 mm on every feature inflates cost with zero functional gain. Tolerance should follow function and risk class.

General features: ±0.1–0.2 mm is the workable band for most medical molded parts.
Critical sealing / locating surfaces: ±0.05 mm achievable with steel-safe tooling; our ECG button held ±0.03 mm on a soft elastomer.
Mold (tool) tolerance: ±0.02 mm on the steel; the part inherits more from shrink and process.
Shrinkage: amorphous (PC, PEI) 0.4–0.8%; semi-crystalline (PP, PEEK) 1.0–2.0%; LSR 2–3%.

Traceability and quality system

A supplier without medical-quality documentation cannot release device parts regardless of part quality. These anchors are what the audit asks for first.

ISO 13485 is the medical-device QMS standard — the counterpart to automotive IATF 16949.
Lot-level traceability: every resin lot carries a cert (biocompatibility, melt-flow, tensile); the molded part maps to resin lot, machine and cycle. Lost trace blocks a recall investigation.
PPAP / validation: first-article proof — design record, material cert, dimensional report, process FMEA and a capability study. A typical requirement is Cpk ≥ 1.33 on critical characteristics; Cpk ≥ 1.67 for safety-critical items.
FDA QSR / 21 CFR 820 and cGMP discipline underpin production release in regulated markets.

Our balun program shipped PEI with full lot certs at 15,000+ units/year, 8 weeks DFM-to-PPAP — the same capability logic a medical device audit expects.

Prototype to production: one supplier path

Keeping DFM, tooling, molding and validation under one roof means the learning from the first shot feeds the production tool instead of getting lost in a handoff.

DFM review — wall thickness, draft, gate, weld-line and ejector-mark risks reviewed against the sterilization and tolerance before steel is cut.
Rapid tooling — aluminum or soft-steel tool for clinical/validation builds; first parts in 3–5 weeks.
Production tooling — hardened multi-cavity steel; full PPAP/validation; shipment at 8–12 weeks from DFM release.
Traceability handoff — lot-level material cert, Cpk data and E&L dossier fed into the device record.

Running validation at shop A and production at shop B doubles cost because shop B re-learns the part. One supplier from prototype to shipment is the cheaper path.

Where medical molding goes wrong

Wrong sterilization resin: gamma-embrittled PP or autoclave-melted ABS → field failure.
No biocompatibility cert → cannot clear ISO 10993 / USP Class VI; release stalls.
Over-toleranced print → 30% unit-cost premium on features that never locate.
Supplier without ISO 13485 → cannot pass the device audit.
Lost lot traceability → investigation cannot map a defect to resin/machine/cycle.

Every one of these is a spec decision, not a molding defect. The print sets the outcome before the first shot.

Compliance pass

Bring the print and the device spec — body contact vs external, sterilization method, and which compliance anchors the program requires (ISO 13485, ISO 10993 level, PPAP). We return a material and process plan that meets the sterilization and traceability gate, with lot-level certs and Cpk data built in from the first shot.

Medical Injection Molding — Material & Traceability Guide